Cargando…
MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer
BACKGROUND: Cancer cells develop resistance to chemotherapeutic intervention by excessive formation of stress granules (SGs), which are modulated by an oncogenic protein G3BP2. Selective control of G3BP2/SG signaling is a potential means to treat non-small cell lung cancer (NSCLC). METHODS: Co-immun...
Autores principales: | Li, Haichang, Lin, Pei-Hui, Gupta, Pranav, Li, Xiangguang, Zhao, Serena Li, Zhou, Xinyu, Li, Zhongguang, Wei, Shengcai, Xu, Li, Han, Renzhi, Lu, Jing, Tan, Tao, Yang, Dong-Hua, Chen, Zhe-Sheng, Pawlik, Timothy M., Merritt, Robert E., Ma, Jianjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439062/ https://www.ncbi.nlm.nih.gov/pubmed/34521423 http://dx.doi.org/10.1186/s12943-021-01418-3 |
Ejemplares similares
-
MG53 Mitigates Nitrogen Mustard-Induced Skin Injury
por: Li, Haichang, et al.
Publicado: (2023) -
MG53 attenuates nitrogen mustard‐induced acute lung injury
por: Li, Haichang, et al.
Publicado: (2022) -
MG53 inhibits cellular proliferation and tumor progression in colorectal carcinoma
por: Gupta, Pranav, et al.
Publicado: (2022) -
Sustained delivery of rhMG53 promotes diabetic wound healing and hair follicle development
por: Niu, Hong, et al.
Publicado: (2022) -
MG53 suppresses interferon-β and inflammation via regulation of ryanodine receptor-mediated intracellular calcium signaling
por: Sermersheim, Matthew, et al.
Publicado: (2020)